James Cohen Stuart
Overview
Explore the profile of James Cohen Stuart including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
364
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rouard C, Greig D, Tauhid T, Dupke S, Njamkepo E, Amato E, et al.
Euro Surveill
. 2024 Sep;
29(36).
PMID: 39239731
BackgroundThe number of cholera cases reported to the World Health Organization (WHO) in 2022 was more than double that of 2021. Nine countries of the WHO European Region reported 51...
2.
Euser S, Weenink T, Prins J, Haverkort M, Manders I, van Lelyveld S, et al.
Diagnostics (Basel)
. 2022 Mar;
12(3).
PMID: 35328272
Background: We assessed the SARS-CoV-2 reinfection rate in a large patient cohort, and evaluated the effect of varying time intervals between two positive tests on assumed reinfection rates using viral...
3.
Euser S, Aronson S, Manders I, van Lelyveld S, Herpers B, Sinnige J, et al.
Int J Epidemiol
. 2022 Jan;
50(6):1795-1803.
PMID: 34999848
Background: Describing the SARS-CoV-2 viral-load distribution in different patient groups and age categories. Methods: All results from first nasopharyngeal (NP) and oropharyngeal (OP) swabs from unique patients tested via SARS-CoV-2...
4.
Cohen Stuart J, Leverstein-Van Hall M, Kortmann W, Verlind J, Mulder F, Scharringa J, et al.
Eur J Clin Microbiol Infect Dis
. 2018 Aug;
37(10):2021-2025.
PMID: 30117050
This study aimed to evaluate the clinical and bacteriological effect of oral treatment with ceftibuten plus amoxicillin-clavulanic acid in patients with a urinary tract infection (UTI) caused by an extended-spectrum...
5.
van den Bijllaardt W, Schijffelen M, Bosboom R, Cohen Stuart J, Diederen B, Kampinga G, et al.
J Antimicrob Chemother
. 2018 Jul;
73(9):2380-2387.
PMID: 29982660
Objectives: Fosfomycin susceptibility testing is complicated and prone to error. Before using fosfomycin widely in patients with serious infections, acquisition of WT distribution data and reliable susceptibility testing methods are...
6.
Smith M, Diederen B, Scharringa J, Hall M, Fluit A, Cohen Stuart J
J Med Microbiol
. 2016 Jul;
65(9):951-953.
PMID: 27451855
Rapid and accurate detection of carbapenemase-producing Enterobacteriaceae is pivotal for adequate antibiotic therapy and infection control. The Cepheid Xpert Carba-R assay detects and identifies the most prevalent carbapenemases (KPC, VIM,...
7.
van der Zee A, Roorda L, Bosman G, Fluit A, Hermans M, Smits P, et al.
BMC Infect Dis
. 2014 Jan;
14:27.
PMID: 24422880
Background: Resistance to carbapenem antibiotics is emerging worldwide among Enterobacteriaceae. To prevent hospital transmission due to unnoticed carriage of carbapenemase producing micro-organisms in newly admitted patients, or follow-up of patients...
8.
Voets G, Fluit A, Scharringa J, Schapendonk C, van den Munckhof T, Leverstein-van Hall M, et al.
Int J Food Microbiol
. 2013 Nov;
167(3):359-62.
PMID: 24184615
The increasing prevalence of third-generation cephalosporin-resistant Enterobacteriaceae is a worldwide problem. Recent studies showed that poultry meat and humans share identical Extended-Spectrum Beta-Lactamase genes, plasmid types, and Escherichia coli strain...
9.
Leverstein-van Hall M, Waar K, Muilwijk J, Cohen Stuart J
J Antimicrob Chemother
. 2013 Jun;
68(11):2636-40.
PMID: 23766488
Objectives: The CLSI recommends a fixed 2 : 1 ratio of co-amoxiclav for broth microdilution susceptibility testing of Enterobacteriaceae, while EUCAST recommends a fixed 2 mg/L clavulanate concentration. The aims...
10.
Voets G, Platteel T, Fluit A, Scharringa J, Schapendonk C, Cohen Stuart J, et al.
PLoS One
. 2013 Jan;
7(12):e52102.
PMID: 23284886
There is a global increase in infections caused by Enterobacteriaceae with plasmid-borne β-lactamases that confer resistance to third-generation cephalosporins. The epidemiology of these bacteria is not well understood, and was,...